Symposia: Outcomes Research—Non-Malignant Conditions
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Biological therapies, adult, epidemiology, Sickle Cell Trait, Clinical Practice (Health Services and Quality), health outcomes research, Clinical Research, Genetic Disorders, health disparities research, Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, pediatric, patient-reported outcomes, Diseases, Gene Therapy, Therapies, real-world evidence, registries, Adverse Events, young adult , survivorship, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Biological therapies, adult, epidemiology, Sickle Cell Trait, Clinical Practice (Health Services and Quality), health outcomes research, Clinical Research, Genetic Disorders, health disparities research, Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, pediatric, patient-reported outcomes, Diseases, Gene Therapy, Therapies, real-world evidence, registries, Adverse Events, young adult , survivorship, Study Population, Human
Sunday, December 11, 2022: 12:00 PM-1:30 PM
R06-R09
(Ernest N. Morial Convention Center)
Moderators:
Olubusola Oluwole, MD, MS, University of Pittsburgh School of Medicine
and
Sherif M. Badawy, MD, Ann %26 Robert Lurie Children's Hospital
Disclosures:
No relevant conflicts of interest to declare.
This session highlights current treatment outcomes and upcoming therapies in sickle cell disease
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH